中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
43期
6959-6965
,共7页
徐俊%殷潇凡%谷辉杰%秦强
徐俊%慇瀟凡%穀輝傑%秦彊
서준%은소범%곡휘걸%진강
生物材料%骨生物材料%磷酸三钙%骨缺损%骨形态发生蛋白2%血管内皮生长因子
生物材料%骨生物材料%燐痠三鈣%骨缺損%骨形態髮生蛋白2%血管內皮生長因子
생물재료%골생물재료%린산삼개%골결손%골형태발생단백2%혈관내피생장인자
背景:目前治疗骨缺损以植骨为主,其中磷酸三钙是目前广泛使用的人工骨材料,但对于磷酸三钙的植骨效果仍有争议,其治疗骨缺损的机制尚无详细报道。<br> 目的:观察磷酸三钙植骨填充于骨缺损区后,局部骨形态发生蛋白2和血管内皮生长因子的浓度变化及骨愈合情况。<br> 方法:取C57小鼠48只,随机均分为实验组与对照组,切除右侧股骨干中部2 mm长的骨干和骨膜制作单侧股骨缺损模型,实验组于骨缺损处植入磷酸三钙,对照组不植入任何物质。术后1-4周拍摄X射线片观察骨愈合情况,随后处死动物,植骨区取材,通过Elisa法测定样本中骨形态发生蛋白2、血管内皮生长因子的水平。<br> 结果与结论:X射线显示,实验组术后2周时骨折大部分愈合,小部分骨皮质未完全愈合,3周时骨折基本愈合,仍有少量磷酸三钙残留,4周时骨折完全愈合,周围骨痂生长明显,磷酸三钙基本吸收;对照组术后一二周时仍可见骨折线,第3周时可见骨折线模糊,第4周时骨折部分愈合,部分骨皮质未愈合。实验组不同时间点骨形态发生蛋白2、血管内皮生长因子水平均高于对照组(P<0.05)。结果表明磷酸三钙植骨治疗可通过上调骨形态发生蛋白2和血管内皮生长因子的表达,促进骨愈合。
揹景:目前治療骨缺損以植骨為主,其中燐痠三鈣是目前廣汎使用的人工骨材料,但對于燐痠三鈣的植骨效果仍有爭議,其治療骨缺損的機製尚無詳細報道。<br> 目的:觀察燐痠三鈣植骨填充于骨缺損區後,跼部骨形態髮生蛋白2和血管內皮生長因子的濃度變化及骨愈閤情況。<br> 方法:取C57小鼠48隻,隨機均分為實驗組與對照組,切除右側股骨榦中部2 mm長的骨榦和骨膜製作單側股骨缺損模型,實驗組于骨缺損處植入燐痠三鈣,對照組不植入任何物質。術後1-4週拍攝X射線片觀察骨愈閤情況,隨後處死動物,植骨區取材,通過Elisa法測定樣本中骨形態髮生蛋白2、血管內皮生長因子的水平。<br> 結果與結論:X射線顯示,實驗組術後2週時骨摺大部分愈閤,小部分骨皮質未完全愈閤,3週時骨摺基本愈閤,仍有少量燐痠三鈣殘留,4週時骨摺完全愈閤,週圍骨痂生長明顯,燐痠三鈣基本吸收;對照組術後一二週時仍可見骨摺線,第3週時可見骨摺線模糊,第4週時骨摺部分愈閤,部分骨皮質未愈閤。實驗組不同時間點骨形態髮生蛋白2、血管內皮生長因子水平均高于對照組(P<0.05)。結果錶明燐痠三鈣植骨治療可通過上調骨形態髮生蛋白2和血管內皮生長因子的錶達,促進骨愈閤。
배경:목전치료골결손이식골위주,기중린산삼개시목전엄범사용적인공골재료,단대우린산삼개적식골효과잉유쟁의,기치료골결손적궤제상무상세보도。<br> 목적:관찰린산삼개식골전충우골결손구후,국부골형태발생단백2화혈관내피생장인자적농도변화급골유합정황。<br> 방법:취C57소서48지,수궤균분위실험조여대조조,절제우측고골간중부2 mm장적골간화골막제작단측고골결손모형,실험조우골결손처식입린산삼개,대조조불식입임하물질。술후1-4주박섭X사선편관찰골유합정황,수후처사동물,식골구취재,통과Elisa법측정양본중골형태발생단백2、혈관내피생장인자적수평。<br> 결과여결론:X사선현시,실험조술후2주시골절대부분유합,소부분골피질미완전유합,3주시골절기본유합,잉유소량린산삼개잔류,4주시골절완전유합,주위골가생장명현,린산삼개기본흡수;대조조술후일이주시잉가견골절선,제3주시가견골절선모호,제4주시골절부분유합,부분골피질미유합。실험조불동시간점골형태발생단백2、혈관내피생장인자수평균고우대조조(P<0.05)。결과표명린산삼개식골치료가통과상조골형태발생단백2화혈관내피생장인자적표체,촉진골유합。
BACKGROUND:Currently, bone graft is mainly used for repair of bone defects, and tricalcium phosphate is the most used artificial bone material. But the effectiveness of the tricalcium phosphate bone graft is stil controversial, and there is also no detailed report about its function during the healing of bone defect. <br> OBJECTIVE:To observe the concentration changes of bone morphogenetic protein-2 and vascular endothelial growth factor as wel as bone healing after tricalcium phosphate graft in bone defects. <br> METHODS:Forty-eight C57 mice were randomly divided to experimental group and control group. A 2-mm-long diaphyseal segment and periosteum from the middle of the right femur was cut to prepare unilateral bone defect models. Tricalcium phosphate bone graft was used in the experimental group, and no bone graft in the control group. During the fol owing 4 weeks, X-ray examination was done once a week to observe the bone healing, and then the animals were executed for col ecting samples in the graft area. The concentrations of bone morphogenetic protein-2 and vascular endothelial growth factor in samples which were taken from the bone graft area were determined by using ELISA assay. <br> RESULTS AND CONCLUSION:X-ray films showed that 2 weeks later, bone fracture healed mostly in the experimental group except a smal part of cortical bone;3 weeks later, bone fracture was basical y healed, and only a smal amount of tricalcium phosphate remained;4 weeks later, bone fracture was completely healed, and the cal us grew obviously, and the tricalcium phosphate was nearly absorbed. In the control group, the fracture line was stil visible at 1-2 weeks, but it became vague at 3 weeks;then, the fracture was healed at 4 weeks except some of the cortical bone. The levels of bone morphogenetic protein-2 and vascular endothelial growth factor were significantly higher in the experimental group than in the control group at different time points (P<0.05). These results suggest that tricalcium phosphate bone graft can up-regulate the expression of bone morphogenetic protein-2 and vascular endothelial growth factor and accelerate bone healing.